New Approaches for the Identification of Drug Targets in Protozoan Parasites - International Review of Cell and Molecular Biology - page 392

Gego, A., Silvie, O., Franetich, J.F., Farhati, K., Hannoun, L., Luty, A.J., Sauerwein, R.W.,
Boucheix, C., Rubinstein, E., Mazier, D., 2006. New approach for high-throughput
screening of drug activity on Plasmodium liver stages. Antimicrob. Agents Chemother.
50, 1586-1589.
Gilk, S.D., Gaskins, E., Ward, G.E., Beckers, C.J., 2009. GAP45 phosphorylation controls
assembly of the Toxoplasma myosin XIV complex. Eukaryot. Cell. 8, 190-196.
Goodman, C.D., McFadden, G.I., 2007. Fatty acid biosynthesis as a drug target in apicom-
plexan parasites. Curr. Drug Targets 8, 15-30.
Gottstein, B., Razmi, G.R., Ammann, P., Sager, H., Müller, N., 2005. Toltrazuril treatment to
control diaplacental Neospora caninum transmission in experimentally infected pregnant
mice. Parasitology 130, 41-48.
Green, J.L., Rees-Channer, R.R., Howell, S.A., Martin, S.R., Knuepfer, E., Taylor,
H.M., Grainger, M., Holder, A.A., 2008. The motor complex of Plasmodium falci-
parum : phosphorylation by a calcium-dependent protein kinase. J. Biol. Chem. 283,
30980-30989.
Greif, G., Harder, A., Haberkorn, A., 2001. Chemotherapeutic approaches to protozoa: Coc-
cidiae-current level of knowledge and outlook. Parasitol. Res. 87, 973-975.
Gubbels, M.J., Li, C., Striepen, B., 2003. High-throughput growth assay for Toxoplasma gondii
using yellow fluorescent protein. Antimicrob. Agents Chemother. 47, 309-316.
Haerdi, C., Haessig, M., Sager, H., Greif, G., Staubli, D., Gottstein, B., 2006. Humoral immune
reaction of newborn calves congenitally infected with Neospora caninum and experimen-
tally treated with toltrazuril. Parasitol. Res. 99, 534-540.
Hall, B.S., Wilkinson, S.R., 2012. Activation of benznidazole by trypanosomal type I nitro-
reductases results in glyoxal formation. Antimicrob. Agents Chemother. 56, 115-123.
Hall, B.S., Wu, X., Hu, L., Wilkinson, S.R., 2010. Exploiting the drug-activating properties
of a novel trypanosomal nitroreductase. Antimicrob. Agents Chemother. 54, 1193-1199.
Hammarton, T.C., Mottram, J.C., Doerig, C., 2003. The cell cycle of parasitic protozoa:
potential for chemotherapeutic exploitation. Prog. Cell. Cycle Res. 5, 91-101.
Hardré, R., Salmon, L., Opperdoes, F.R., 2000. Competitive inhibition of Trypanosoma brucei
phosphoglucose isomerase by D-arabinose-5-phosphate derivatives. J. Enzym. Inhib. 15,
509-515.
Haste, N.M., Talabani, H., Doo, A., Merckx, A., Langsley, G., Taylor, S.S., 2012. Exploring
the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein
kinase (PfPKA) as a therapeutic target. Microbes Infect. 14, 838-850.
Havens, C.G., Bryant, N., Asher, L., Lamoreaux, L., Perfetto, S., Brendle, J.J., Werbovetz, K.A.,
2000. Cellular effects of leishmanial tubulin inhibitors on L. donovani . Mol. Biochem.
Parasitol. 110, 223-226.
Hazleton, K.Z., Ho, M.C., Cassera, M.B., Clinch, K., Crump, D.R., Rosario, I.J., Merino,
E.F., Almo, S.C., Tyler, P.C., Schramm, V.L., 2012. Acyclic immucillin phosphonates:
second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine
phosphoribosyltransferase. Chem. Biol. 19, 721-730.
He, D., Wen, J.F., Chen, W.Q., Lu, S.Q., Xin, D.D., 2005. Identification, characteristic and
phylogenetic analysis of type II DNA topoisomerase gene in Giardia lamblia . Cell. Res.
15, 474-482.
Hemphill, A., Mueller, J., Esposito, M., 2006. Nitazoxanide, a broad-spectrum thiazolide
anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Phar-
macother. 7, 953-964.
Hemphill, A., Müller, J., 2009. Alveolar and cystic echinococcosis: towards novel chemo-
therapeutical treatment options. J. Helminthol. 83, 99-111.
Hemphill, A., Müller, N., Müller, J., 2007. Structure-function relationship of thiazolides, a
novel class of anti-parasitic drugs, investigated in intracellular and extracellular protozoan
parasites and larval-stage cestodes. Antiinf. Agents Med. Chem 6, 273-282.